These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11390034)

  • 1. Noncytolytic human lymphocytes injure dermal microvessels in the huPBL-SCID skin graft model.
    Rayner D; Nelson R; Murray AG
    Hum Immunol; 2001 Jun; 62(6):598-606. PubMed ID: 11390034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermal microvascular injury in the human peripheral blood lymphocyte reconstituted-severe combined immunodeficient (HuPBL-SCID) mouse/skin allograft model is T cell mediated and inhibited by a combination of cyclosporine and rapamycin.
    Murray AG; Schechner JS; Epperson DE; Sultan P; McNiff JM; Hughes CC; Lorber MI; Askenase PW; Pober JS
    Am J Pathol; 1998 Aug; 153(2):627-38. PubMed ID: 9708821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The allogeneic response to cultured human skin equivalent in the hu-PBL-SCID mouse model of skin rejection.
    Briscoe DM; Dharnidharka VR; Isaacs C; Downing G; Prosky S; Shaw P; Parenteau NL; Hardin-Young J
    Transplantation; 1999 Jun; 67(12):1590-9. PubMed ID: 10401767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of fetal skin grafts is prolonged on the human peripheral blood lymphocyte reconstituted-severe combined immunodeficient mouse/skin allograft model.
    Erdag G; Morgan JR
    Transplantation; 2002 Feb; 73(4):519-28. PubMed ID: 11889422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic human skin graft rejection in severe combined immunodeficient mice engrafted with human PBL from an HLA-presensitized donor.
    Kawamura T; Niguma T; Fechner JH; Wolber R; Beeskau MA; Hullett DA; Sollinger HW; Burlingham WJ
    Transplantation; 1992 Mar; 53(3):659-65. PubMed ID: 1549862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alloimmune injury and rejection of human skin grafts on human peripheral blood lymphocyte-reconstituted non-obese diabetic severe combined immunodeficient beta2-microglobulin-null mice.
    Turgeon NA; Banuelos SJ; Shultz LD; Lyons BL; Iwakoshi N; Greiner DL; Mordes JP; Rossini AA; Appel MC
    Exp Biol Med (Maywood); 2003 Oct; 228(9):1096-104. PubMed ID: 14530522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T-cell-mediated destruction of allogeneic dermal microvessels in a severe combined immunodeficient mouse.
    Murray AG; Petzelbauer P; Hughes CC; Costa J; Askenase P; Pober JS
    Proc Natl Acad Sci U S A; 1994 Sep; 91(19):9146-50. PubMed ID: 8090783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
    Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
    Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-11 protects human microvascular endothelium from alloinjury in vivo by induction of survivin expression.
    Kirkiles-Smith NC; Mahboubi K; Plescia J; McNiff JM; Karras J; Schechner JS; Altieri DC; Pober JS
    J Immunol; 2004 Feb; 172(3):1391-6. PubMed ID: 14734714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for CD2 antibodies (BTI-322 and its humanized form) in the in vivo elimination of human T lymphocytes infiltrating an allogeneic human skin graft in SCID mice: an Fcgamma receptor-related mechanism involving co-injected human NK cells.
    Snanoudj R; Rouleau M; Bidère N; Carmona S; Baron C; Latinne D; Bazin H; Charpentier B; Senik A
    Transplantation; 2004 Jul; 78(1):50-8. PubMed ID: 15257038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human allogeneic vascular rejection after arterial transplantation and peripheral lymphoid reconstitution in severe combined immunodeficient mice.
    Lorber MI; Wilson JH; Robert ME; Schechner JS; Kirkiles N; Qian HY; Askenase PW; Tellides G; Pober JS
    Transplantation; 1999 Mar; 67(6):897-903. PubMed ID: 10199740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An in vivo model of human skin acute graft-versus-host disease: transplantation of cultured human epidermal cells and dermal fibroblasts with human lymphocytes into SCID mice.
    Takakura I; Yabe M; Kato Y; Matsumoto M; Yabe H; Inokuchi S; Kidokoro M; Takakura I; Shimamura K; Kato S
    Exp Hematol; 1999 Dec; 27(12):1815-21. PubMed ID: 10641599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-12 delivered by biodegradable microspheres promotes the antitumor activity of human peripheral blood lymphocytes in a human head and neck tumor xenograft/SCID mouse model.
    Kuriakose MA; Chen FA; Egilmez NK; Jong YS; Mathiowitz E; DeLacure MD; Hicks WL; Loree TL; Bankert RB
    Head Neck; 2000 Jan; 22(1):57-63. PubMed ID: 10585606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic versus xenogeneic immune reaction to bioengineered skin grafts.
    Erdag G; Morgan JR
    Cell Transplant; 2004; 13(6):701-12. PubMed ID: 15648740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cell-mediated rejection of porcine xenografts in an immunodeficient mouse model.
    Sawada T; DellaPelle PA; Seebach JD; Sachs DH; Colvin RB; Iacomini J
    Transplantation; 1997 May; 63(9):1331-8. PubMed ID: 9158029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xenogeneic (bovine) peripheral blood leukocytes engrafted into severe combined immunodeficient mice retain primary immune function.
    Greenwood JD; Croy BA; Trout DR; Wilcock BP
    Vet Immunol Immunopathol; 1997 Oct; 59(1-2):93-112. PubMed ID: 9437828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal analysis of the lymphoid cells mediating skin allograft rejection. Mediation of graft rejection in vivo by cloned Lyt-1+2- proliferative, noncytotoxic long-term cell lines.
    Kim B; Rosenstein M; Weiland D; Eberlein TJ; Rosenberg SA
    Transplantation; 1983 Nov; 36(5):525-32. PubMed ID: 6356516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediation of skin allograft rejection in scid mice by CD4+ and CD8+ T cells.
    Shelton MW; Walp LA; Basler JT; Uchiyama K; Hanto DW
    Transplantation; 1992 Aug; 54(2):278-86. PubMed ID: 1353912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis in the huPBL-SCID model of human transplant rejection.
    Moulton KS; Melder RJ; Dharnidharka VR; Hardin-Young J; Jain RK; Briscoe DM
    Transplantation; 1999 Jun; 67(12):1626-31. PubMed ID: 10401773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human myeloid dendritic cells transduced with an adenoviral interleukin-10 gene construct inhibit human skin graft rejection in humanized NOD-scid chimeric mice.
    Coates PT; Krishnan R; Kireta S; Johnston J; Russ GR
    Gene Ther; 2001 Aug; 8(16):1224-33. PubMed ID: 11509955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.